United States
A-3
PKA inhibitor
| BML-EI145-0010 | 10 mg | 67.00 USD |  |
||
| BML-EI145-0050 | 50 mg | 272.00 USD | |
||
Replaces Prod. #: ALX-270-039
Inhibitor of cAMP- and cGMP-dependent protein kinase (PKA, Ki=4.3µM and PKG, Ki=3.8µM), protein kinase C (PKC, Ki=47µM), casein kinase I and II, and myosin light chain kinase (MLCK, Ki=7.4µM).
Product Specification
| Formula: | C12H13ClN2O2S . HCl |
| MW: | 284.8 . 36.5 |
| Purity: | ≥98% |
| Appearance: | White to off-white solid. |
| CAS: | 78957-85-4 |
| Solubility: | Soluble in water (50mg/ml), DMSO (50mg/ml) or 100% ethanol. |
| Long Term Storage: | +4°C |
| Use/Stability: | Stable for at least 2 years after receipt when stored at +4°C. Stock solutions are stable for up to 3 months at -20°C. |
| Background / Technical Information: | Note: Product is not sterile.Please click here for the comprehensive product datasheet. |
Please mouse over
Product Literature References
Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors: M. Inagaki, et al.; Mol. Pharmacol. 29, 577 (1986), Abstract;
Product Toolbox
PRODUCT RESOURCES
Datasheet
MSDS
RELATED PRODUCTS
By catalog section:
By biological activity:
PKA InhibitorPRODUCT SUPPORT
Technical ServiceBulk Quantity Quote
Customer Service
